Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Iron Toxicity Management

Clinical Manifestations and Management

  • Chronic fatigue, joint pain, and abdominal pain are manifestations of chronic iron overload, according to the American College of Physicians 1
  • Skin pigmentation changes, endocrine manifestations such as diabetes mellitus and hypogonadism, and cardiac manifestations like cardiomyopathy and heart failure are associated with chronic iron overload 1
  • Cardiac manifestations, including cardiomyopathy, dysrhythmias, and heart failure, are linked to chronic iron overload, as stated by the American Heart Association 2
  • Hepatic manifestations, such as elevated liver enzymes, progressive fibrosis, cirrhosis, and hepatocellular carcinoma, are associated with chronic iron overload 1

Pediatric Considerations

  • Children aged 9-18 months are at highest risk for iron deficiency due to rapid growth and frequently inadequate dietary iron intake, according to the Centers for Disease Control and Prevention 4
  • In children with hemoglobinopathy receiving transfusion and chelation, cardiac iron overload typically occurs after 10 years of age, as reported by the American Heart Association 2
  • Preterm and low-birthweight infants are at greater risk for iron deficiency than full-term infants, as stated by the Centers for Disease Control and Prevention 4

Parenteral Iron Administration

  • Iron supplementation should preferentially be given enterally rather than parenterally when tolerated, as recommended by the European Society for Clinical Nutrition and Metabolism 3
  • Routine parenteral iron supplements should be given at a dose of 200-250 μg/kg/day in preterm infants and 50-100 μg/kg/day in infants and children, according to the European Society for Clinical Nutrition and Metabolism 3
  • Systemic iron toxicity with hepatocellular damage has been observed in a pediatric patient receiving 16 mg/kg of iron sucrose, as reported by the European Society for Clinical Nutrition and Metabolism 3

Monitoring and Treatment

  • Regular assessment of iron status, including ferritin and hemoglobin, is crucial in patients on long-term parenteral nutrition, as recommended by the European Society for Clinical Nutrition and Metabolism 3
  • MRI with quantitative assessment of iron content is used for cardiac and hepatic iron load monitoring, according to the American College of Physicians 1
  • Delayed diagnosis of iron overload can lead to irreversible organ damage, emphasizing the importance of prompt diagnosis and treatment, as stated by the American College of Physicians 1
  • Early treatment before development of cirrhosis and/or diabetes significantly reduces morbidity and mortality, as reported by the American College of Physicians 1